Alcohol‑Induced Impairment of Thyroid Hormone Conversion and Clinical Implications

Hepatic Impairment of Peripheral T4→T3 Conversion

The liver is the principal site for conversion of thyroxine (T4) to triiodothyronine (T3); alcohol‑related liver disease directly reduces this metabolic function, leading to lower peripheral T3 levels【1】.
Chronic high‑dose alcohol intake generates oxidative stress, lipid peroxidation, and mitochondrial injury in hepatocytes, which disrupt deiodinase enzyme activity and further diminish T4‑to‑T3 conversion【2】.
Even mild alcohol‑induced liver injury is sufficient to cause a measurable decline in peripheral T3 production, independent of the severity of other systemic effects【2】.
The severity of liver disease correlates with the magnitude of conversion impairment; patients with minimal hepatic damage already exhibit altered thyroid hormone metabolism【1】【2】.

Lowered T3 availability impairs regulation of glucose metabolism, contributing to alcohol‑related metabolic dysregulation and increasing the risk of hyperglycemia【3】.
The combined impact of alcohol’s direct metabolic toxicity and the secondary reduction in T3 creates a compounded metabolic disturbance that can exacerbate dyslipidemia (especially elevated triglycerides) and reduce cardiac contractility【3】【4】.
Components of the metabolic syndrome—hypertension, hyperglycemia, and dyslipidemia—are amplified by the interaction between chronic alcohol use and thyroid dysfunction, producing bidirectional adverse effects【3】【4】.

Comprehensive evaluation of liver function should be performed in patients with chronic alcohol use, because hepatic dysfunction directly impairs T4‑to‑T3 conversion and influences thyroid test interpretation【1】【2】.
After a period of sustained abstinence (≥3–4 weeks), clinicians should reassess thyroid function and also monitor for emergence or worsening of metabolic‑syndrome features that may have been masked by the low‑T3 state【3】【4】.

The liver is the primary site where T4 is converted to T3 through type 1 deiodinase (DIO1), a process that is crucial for the production of the majority of peripheral T3, according to the American Gastroenterological Association 5, 6
The conversion of T4 to T3 is catalyzed primarily by type 1 5'-deiodinase (DIO1), a selenoenzyme, as recommended by the Clinical Nutrition society 7, 8

The conversion process involves monodeiodination, which is primarily catalyzed by type 1 deiodinase (DIO1) in the liver, and requires selenium as a cofactor for the deiodinase enzymes, as stated by the Clinical Nutrition society 5, 7, 8
The process is ATP-dependent and requires selenium as a cofactor for the deiodinase enzymes, which is essential for the proper functioning of these enzymes, according to the Clinical Nutrition society 7, 8

The peripheral conversion of T4 to T3 is essential for normal thyroid hormone action, since T3 is the major active form of thyroid hormone, as reported by the Natural Product Reports 9, 10, 11
Iron deficiency can impair thyroid metabolism and affect the conversion process, which can lead to relative T3 deficiency despite normal T4 levels, as stated by the Clinical Nutrition society 8

Nutritional factors, particularly selenium status, can affect deiodinase activity since these are selenoenzymes, which is crucial for the proper functioning of these enzymes, according to the Clinical Nutrition society 7, 8